Related Experiment Video
Updated: Jun 13, 2026
10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Real-life experiences in migraine therapy
P Turcani1, D Farkasova, T Marcek
11st Department of Neurology, Faculty of Medicine, Comenius University in Bratislava, Slovakia. peter.turcani@faneba.sk
Bratislavske Lekarske Listy
|May 1, 2010
Summary
Eletriptan effectively treats acute migraine, with high patient satisfaction and preference. This study shows its efficacy in real-world clinical settings for migraine management.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a common neurological disorder impacting millions worldwide.
- Acute treatment options are crucial for managing debilitating migraine attacks.
Purpose of the Study:
- To assess the real-world effectiveness of eletriptan for acute migraine.
- To evaluate patient satisfaction with eletriptan in typical clinical practice.
Main Methods:
- A study involving 637 male and female patients aged 18-65 meeting International Headache Society criteria for migraine.
- Patients were treated by practicing neurologists in usual clinical settings.
Main Results:
- Eletriptan demonstrated a 59.5% headache response at 1 hour post-dose across three attacks.
- Significant improvements were noted in pain-free status (13%), absence of vomiting (86.3%), and functioning (55%).
- Patient preference for eletriptan over previous triptans was exceptionally high at 97%.
Conclusions:
- Eletriptan shows high efficacy and consistent response in real-life migraine treatment.
- The drug was highly preferred by patients, indicating strong satisfaction and potential for improved adherence.
